Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply - Zhen Gao; Shujie Huang; Sichao Wang; Dezhao Tang; Wei Xu; Ruijie Zeng; Guibin Qiao (Elsevier, 2023)